Health authorities in Indonesia are reinforcing public health guidance following the detection of a subclade of influenza A (H3N2), popularly referred to as the “super flu”. The strain was first identified in the country on 25 December 2025 and has since been reported in multiple regions, prompting renewed emphasis on vaccination and preventive health behaviours.
According to official data, a total of 62 confirmed cases have been recorded across eight provinces in Indonesia, with the highest numbers reported in East Java, South Kalimantan and West Java. While the situation is being closely monitored, national health officials have stressed that the virus does not present the same level of severity as diseases such as COVID-19 or tuberculosis.
Dr Ngabila Salama, a public health physician in Indonesia, stated that annual influenza vaccination remains the most effective and practical measure to reduce the risk of infection and severe illness. He emphasised that the flu vaccine is safe, does not cause influenza, and is strongly recommended, particularly for families and public service workers who may have higher exposure risks.
Beyond immunisation, Indonesian health experts are encouraging the population to adopt lifestyle practices that support immune function. Dr Salama highlighted the importance of wearing face masks when experiencing cold symptoms or when in crowded environments, along with regular handwashing to limit viral transmission.
Adequate sleep and stress management were also identified as critical factors influencing immune resilience. “Immunity is strongly affected by sleep quality and stress levels,” Dr Salama noted, adding that maintaining balanced daily routines can help the body respond more effectively to viral threats.
Nutritional habits have also been placed at the centre of prevention strategies in Indonesia. Public health guidance advises increasing protein intake and ensuring sufficient consumption of vegetables and fruit, while avoiding excessive reliance on carbohydrates alone. Proper hydration is likewise recommended as part of a comprehensive approach to maintaining overall health during periods of heightened viral circulation.
Indonesia’s Minister of Health, Budi Gunadi Sadikin, addressed public concerns by explaining that the identified H3N2 subclade does not exhibit the high mortality associated with previous global health emergencies. Nevertheless, he underscored the need for vigilance, particularly during seasonal peaks of respiratory infections.
Scientific literature supports these recommendations, with studies published in journals such as The Lancet Infectious Diseases and Clinical Infectious Diseases demonstrating that influenza vaccination significantly reduces hospitalisation and complications, while adequate nutrition and sleep contribute to more robust immune responses.
As surveillance continues in Indonesia, health authorities are urging citizens not to delay vaccination and to adhere to preventive measures. Officials reiterate that early action and sustained public cooperation remain essential to limiting the spread of influenza strains and protecting vulnerable populations.